Home > Financial Ratios > HALEOS LABS

HALEOS LABS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for HALEOS LABS
Please provide your vote to see the results

HALEOS LABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 11.7711.669.218.058.88

What is the latest Core EBITDA Margin ratio of HALEOS LABS ?

The latest Core EBITDA Margin ratio of HALEOS LABS is 11.77 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202611.77
Mar202511.66
Mar20249.21
Mar20238.05
Mar20228.88

How is Core EBITDA Margin of HALEOS LABS Trending?

Years Core EBITDA Margin % Change
Mar2026 11.77
0.94
Mar2025 11.66
26.60
Mar2024 9.21
14.41
Mar2023 8.05
-9.35
Mar2022 8.88 -

Other Financial Ratios of HALEOS LABS


Compare Core EBITDA Margin ratio of peers of HALEOS LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HALEOS LABS ₹464.1 Cr -0.1% 0.3% 16.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


HALEOS LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HALEOS LABS

-0.1%

0.3%

16.2%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses